NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

dennisdave,

"tens of patients with other cancers"
First, did you see cancer in plural form?

Second, what's your point? Are you trying to say DCVax-L is not working on other solid tumors?

It works and today it works even better with improved formula. The Ovarian trial you talked about is old story based on old formula.

I mentioned repeatedly that one amazing part about DCVax-L is that success in animal model and ex vivo will automatically translate to success in humans, which makes sense since all we need is that DCs can be loaded with tumor-specific antigens, maturated and activated.

Read Dr. Bosch's presentation carefully and ask yourself critical questions.

For instance, there are different types of solid tumors implied in the presentation. You would agree that these tumors came from different patients. Did the dendritic cells come from each patient with a certain type of solid tumors? I doubt it. Most likely, the dendritic cells came from several patients. Could be three or four patients since three example patients were mentioned two times? Do you sense what I mean? It means DCs from any person can be loaded with tumor antigens from someone else tumor tissues. Is that unusual?

How about switching the lane and trying to prove I am right? You may find something completely different.